U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06901245) titled 'Tirzepatide in PWS, HO and GNSO' on March 14.
Brief Summary: This research study is comparing the effectiveness of a weight loss medication called Tirzepatide in young adults with Prader-Willi Syndrome and/or hypothalamic obesity, as compared to young adults with obesity that is unrelated to a genetic syndrome or underlying medical cause. These groups will be given medication for 1 year to see how weight and other health factors are effected by the medication.
Study Start Date: March, 2025
Study Type: INTERVENTIONAL
Condition:
Prader-Willi Syndrome
Hypothalamic Obesity
Obesity/Therapy
Intervention:
DRUG: Tirzepatide
Subjects...